Related Experiment Video
Updated: Jun 27, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway
Lei Yan1,2, Ruhao Zhou1,2, Yi Feng1,2
1Second Clinical Medical College, Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi, 030001, China.
Abstract:
Micro RNAs (miRs) have been implicated in various tumorigenic processes. Osteosarcoma (OS) is a primary bone malignancy seen in adolescents. However, the mechanism of miRs in OS has not been fully demonstrated yet. Here, miR-134-5p was found to inhibit OS progression and was also expressed at significantly lower levels in OS tissues and cells relative to normal controls. miR-134-5p was found to reduce vasculogenic mimicry, proliferation, invasion, and migration of OS cells, with miR-134-5p knockdown having the opposite effects. Mechanistically, miR-134-5p inhibited expression of the ITGB1/MMP2/PI3K/Akt axis, thus reducing the malignant features of OS cells. In summary, miR-134-5p reduced OS tumorigenesis by modulation of the ITGB1/MMP2/PI3K/Akt axis, suggesting the potential for using miR-134-5p as a target for treating OS.
Insights
MicroRNAs (miRs), specifically miR-134-5p, inhibit osteosarcoma progression by downregulating the ITGB1/MMP2/PI3K/Akt pathway. Lower miR-134-5p levels correlate with increased tumor malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRs) play crucial roles in various cellular processes, including tumorigenesis.
- Osteosarcoma (OS) is a prevalent bone cancer in adolescents, but the specific roles of miRs in its development are not fully understood.
Purpose of the Study:
- To investigate the role and mechanism of miR-134-5p in osteosarcoma progression.
- To determine if miR-134-5p can be a therapeutic target for osteosarcoma.
Main Methods:
- Quantitative real-time PCR to measure miR-134-5p expression in OS tissues and cells.
- In vitro assays to assess the effects of miR-134-5p on OS cell proliferation, migration, invasion, and vasculogenic mimicry.
- Western blotting to analyze the expression of proteins in the ITGB1/MMP2/PI3K/Akt pathway.
Main Results:
- miR-134-5p was significantly downregulated in osteosarcoma tissues and cells compared to normal controls.
- Overexpression of miR-134-5p suppressed OS cell proliferation, migration, invasion, and vasculogenic mimicry.
- Knockdown of miR-134-5p promoted these malignant behaviors.
- miR-134-5p inhibited the expression of the ITGB1/MMP2/PI3K/Akt signaling axis.
Conclusions:
- miR-134-5p acts as a tumor suppressor in osteosarcoma by inhibiting the ITGB1/MMP2/PI3K/Akt pathway.
- miR-134-5p holds potential as a therapeutic target for osteosarcoma treatment.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
The JAK-STAT Signaling Pathway

